Steiner Diamond & Co. v. Flashner Medical Partnership

599 N.E.2d 1323, 236 Ill. App. 3d 199, 175 Ill. Dec. 309, 1992 Ill. App. LEXIS 1375
CourtAppellate Court of Illinois
DecidedAugust 28, 1992
DocketNos. 1—90—2402, 1—90—2523 cons.
StatusPublished
Cited by2 cases

This text of 599 N.E.2d 1323 (Steiner Diamond & Co. v. Flashner Medical Partnership) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steiner Diamond & Co. v. Flashner Medical Partnership, 599 N.E.2d 1323, 236 Ill. App. 3d 199, 175 Ill. Dec. 309, 1992 Ill. App. LEXIS 1375 (Ill. Ct. App. 1992).

Opinion

PRESIDING JUSTICE McNULTY

delivered the opinion of the court:

Plaintiff Steiner Diamond appeals the trial court’s dismissal of its contract-based indemnification claim on the grounds that such cause of action was a compulsory counterclaim in a related Federal proceeding. For the reasons which follow, we reverse the decision of the court below.

The immediate parties to the instant action are Steiner Diamond, a Chicago securities broker and dealer, and the Flashner Medical Partnership (FMP), an Illinois partnership engaged in the practice of medicine. Also involved in the events preceding the litigation at bar is Doctor’s Officenter Corporation (DOC), an Illinois corporation owning doctors’ offices staffed by physicians provided by FMP. In addition to providing the medical services at DOC’s numerous physical facilities, FMP owned a controlling interest in DOC. Furthermore, the managing and senior partners in FMP were also the officers and directors of DOC.

On December 7, 1983, DOC made a public offering of its common stock by selling such stock to multiple securities dealers, or underwriters, one of these being Steiner Diamond. The underwriters formed among themselves a syndicate managed by Steiner Diamond to make a retail distribution of the stock to their own retail customers. Warranties and representations made by DOC to the underwriters were contained in a written contract, or underwriting agreement. FMP was also a signing and contracting party to the underwriting agreement and joined in DOC’s undertakings, warranties, and representations to the underwriters.

The DOC stock being publicly offered was registered with the United States Securities and Exchange Commission (SEC) for public sale under a registration statement filed with the SEC by DOC and signed by some of DOC’s officers and all of its directors. Part of that registration statement was a prospectus which was also the legally required disclosure document to accompany each sale to each investor.

About 10 months after the public offering, DOC experienced financial difficulties and decided to liquidate by selling its operating assets to another company. Following this transaction, the public offering investors suffered a loss of more than two-thirds of their investment, an amount considerably higher than that lost by the direct and indirect owners of DOC such as FMP. Five of these investors, all of whom were Steiner Diamond customers, initiated a Federal lawsuit based on alleged fraudulent statements or material omissions in the prospectus generated for the public offering of DOC. (Plaintiff’s twin theories of recovery were violation of the general antifraud provisions of SEC Rule 10b — 5 (17 C.F.R. §240.10b — 5 (1992)) and common law fraud.) The defendants who were sued in the Federal litigation were DOC, all of its officers and directors, its lawyer and his law firm, and FMP.1 Neither Steiner Diamond nor any other underwriter was sued.

In 1988, all of the defendants in the Federal case filed third-party complaints against Steiner Diamond for implied and/or statutory contribution. These actions were premised on the theory that Steiner Diamond was an alleged co-perpetrator or joint tortfeasor of the alleged Rule 10b — 5 violation and fraud (if it was determined that any fraud had in fact been committed).

Steiner Diamond moved to dismiss the Federal third-party actions on grounds which included the nonexistence in law of implied or statutory contribution claims among intentional tortfeasors. These motions were denied and Steiner Diamond was required to answer the third-party actions. Additionally, Steiner Diamond filed three counterclaims in Federal court alleging breach of the representations in the prospectus and registration statement and requesting reimbursement for expenses incurred due to its wrongful involvement in the Federal litigation. Steiner Diamond also filed a counterclaim in State court based on the indemnifying clause of the underwriting agreement. In this section of the agreement, DOC and FMP had agreed to indemnify all underwriters against any expense of defending future litigation based on charges of any untrue or misleading contents of DOC’s prospectus. (This claim, unlike the ones filed in Federal court, did not contain any allegations of breach of contract or wrongful involvement and relied solely on the contractual indemnification provisions of the underwriting agreement.)

FMP at first moved to dismiss this case in the circuit court on the grounds that it was a compulsory counterclaim in the pending Federal litigation which needed to be filed in Federal court (Federal Rules of Civil Procedure 13(a)), and further that the Federal litigation constituted a prior pending case on the same cause of action which would require dismissal under Illinois Code of Civil Procedure section 2— 619. (Ill. Rev. Stat. 1983, ch. 110, par. 2 — 619(a)(3).) This motion was withdrawn before the trial court ruled on it.

Meanwhile, the Federal court granted Steiner Diamond’s motion for judgment on the pleadings as to the third-party actions (for contribution) against it. Even though the Federal court had previously denied Steiner Diamond’s motion to dismiss these claims for contribution on the grounds that there was no cause of action for implied or statutory contribution among joint tortfeasors, it now granted essentially the same relief by means of a judgment on the pleadings.2 Between the two motions, Illinois and Federal law had settled in Steiner Diamond’s favor. The Federal judge in ruling said she was treating the motion for judgment on the pleadings as an appropriate procedural device to reconsider after the close of pleadings the motion to dismiss which she had earlier denied. The Federal court then dismissed Steiner Diamond’s counterclaims without prejudice for lack of subject matter jurisdiction. Thereafter, the remaining parties in the Federal litigation settled, and the case was dismissed. The pending appeals of Steiner Diamond’s judgment on the pleadings were then also voluntarily dismissed in the Seventh Circuit Court of Appeals.

At this point, the only pending litigation was Steiner Diamond’s State court claim. FMP, which had earlier filed and withdrawn a motion to dismiss this claim, now moved again to dismiss the contract-based indemnification claim. Two grounds were alleged: first, that the failure to file this claim as a compulsory counterclaim in the Federal litigation rendered it res judicata by operation of Federal law binding on the Hlinois courts; and, second, that the indemnification provision sued upon did not apply to Steiner Diamond’s expenses in defending the third-party actions.

The trial court dismissed Steiner Diamond’s claim with prejudice, holding that although the terms of the indemnification agreement were applicable to the expenses claimed, Steiner Diamond’s claim was barred, as it was a compulsory counterclaim and, as such, was required to be filed with the Federal lawsuit. Steiner Diamond appealed the dismissal of its lawsuit, and FMP appealed the determination that the indemnification clause was applicable to Steiner Diamond’s expenses.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kapoor v. Fujisawa Pharmaceutical Co.
Appellate Court of Illinois, 1998

Cite This Page — Counsel Stack

Bluebook (online)
599 N.E.2d 1323, 236 Ill. App. 3d 199, 175 Ill. Dec. 309, 1992 Ill. App. LEXIS 1375, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steiner-diamond-co-v-flashner-medical-partnership-illappct-1992.